pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda recalls·2h ago·1 min read
save

Henkel recalls Schwarzkopf Professional Osis Grip mousse in U.S. over packaging leak risk

Aug 11, 2026·read at fda recalls ↗CRLNegative

Henkel Corp announced a voluntary recall of its Schwarzkopf Professional Osis Grip mousse (6.76 fl oz/200 ml) sold in the United States.

The recall is due to a potential packaging defect that could cause the aluminum can to leak under pressure, creating a risk of explosion.

The affected product was distributed through 21 distributors across 12 states and includes specific batch codes listed by the company. No other Henkel products are impacted.

source

This writeup was produced by pharmadog from original reporting by fda recalls.

Original headline: “Henkel Corp. Announces a Nationwide Recall of Schwarzkopf Professional Osis Grip 6.76 fl. Oz/200 ml Due to Packaging Imperfection”

read at fda recalls ↗
415 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Recall7

related stories

  • Jul 24STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and moreSTAT
  • Jul 21Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengeFierce Biotech
  • Jul 21STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreSTAT
  • Jul 21A renewed push from the right against abortion pillsSTAT
  • Jul 20FDA still focused on lettuce supplier as source of parasite, despite faulty test resultSTAT